Safe Tissue Act

H.R. 5209, the Safe Tissue Act, would increase federal oversight of companies that handle human cells and tissues used in medical procedures. The bill requires the Food and Drug Administration (FDA) to inspect these facilities at least once every two years and conduct regular audits to ensure that tissues are obtained legally and without fraud.

For the average citizen, this legislation aims to improve the safety and transparency of tissue transplants, such as skin grafts or bone replacements, by verifying donor medical histories and establishing a standardized consent process. Additionally, the bill would require the government to define "reasonable payments" for tissue recovery to prevent illegal profiting from human remains while ensuring that the personnel handling these materials meet specific accreditation standards.